| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 3051 | 2017 |
| Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the alliance A031203 CABOSUN trial TK Choueiri, S Halabi, BL Sanford, O Hahn, MD Michaelson, MK Walsh, ... Journal of Clinical Oncology 35 (6), 591, 2017 | 814 | 2017 |
| High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis RA Moore, N Adel, E Riedel, M Bhutani, DR Feldman, NE Tabbara, G Soff, ... Journal of Clinical Oncology 29 (25), 3466, 2011 | 479 | 2011 |
| Testicular cancer L Cheng, P Albers, DM Berney, DR Feldman, G Daugaard, T Gilligan, ... Nature Reviews Disease Primers 4 (1), 1-24, 2018 | 462 | 2018 |
| Medical treatment of advanced testicular cancer DR Feldman, GJ Bosl, J Sheinfeld, RJ Motzer Jama 299 (6), 672-684, 2008 | 451 | 2008 |
| Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free … TK Choueiri, C Hessel, S Halabi, B Sanford, MD Michaelson, O Hahn, ... European journal of cancer 94, 115-125, 2018 | 398 | 2018 |
| Integrated molecular characterization of testicular germ cell tumors H Shen, J Shih, DP Hollern, L Wang, R Bowlby, SK Tickoo, V Thorsson, ... Cell reports 23 (11), 3392-3406, 2018 | 381 | 2018 |
| Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma DR Feldman, MS Baum, MS Ginsberg, H Hassoun, CD Flombaum, ... Journal of clinical oncology 27 (9), 1432, 2009 | 347 | 2009 |
| Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ... Cell 185 (3), 563-575. e11, 2022 | 346 | 2022 |
| Testicular cancer survivorship: research strategies and recommendations LB Travis, C Beard, JM Allan, AA Dahl, DR Feldman, J Oldenburg, ... Journal of the national cancer institute 102 (15), 1114-1130, 2010 | 326 | 2010 |
| Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer RD Frisina, HE Wheeler, SD Fossa, SL Kerns, C Fung, HD Sesso, ... Journal of Clinical Oncology 34 (23), 2712, 2016 | 275 | 2016 |
| TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis DR Feldman, J Sheinfeld, DF Bajorin, P Fischer, S Turkula, N Ishill, S Patil, ... Journal of Clinical Oncology 28 (10), 1706, 2010 | 248 | 2010 |
| Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology T Gilligan, DW Lin, R Aggarwal, D Chism, N Cost, IH Derweesh, ... Journal of the National Comprehensive Cancer Network 17 (12), 1529-1554, 2019 | 242 | 2019 |
| Diagnosis and treatment of early stage testicular cancer: AUA guideline A Stephenson, SE Eggener, EB Bass, DM Chelnick, S Daneshmand, ... The Journal of urology 202 (2), 272-281, 2019 | 236 | 2019 |
| Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors A Bagrodia, BH Lee, W Lee, EK Cha, JP Sfakianos, G Iyer, EJ Pietzak, ... Journal of Clinical Oncology 34 (33), 4000, 2016 | 167 | 2016 |
| Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma MI Carlo, S Mukherjee, D Mandelker, J Vijai, Y Kemel, L Zhang, ... JAMA oncology 4 (9), 1228-1235, 2018 | 165 | 2018 |
| Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG Update Consortium S Gillessen, N Sauvé, L Collette, G Daugaard, R de Wit, C Albany, ... Journal of Clinical Oncology 39 (14), 1563-1574, 2021 | 157 | 2021 |
| Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma AM Molina, DR Feldman, MH Voss, MS Ginsberg, MS Baum, DR Brocks, ... Cancer 118 (7), 1868-1876, 2012 | 144 | 2012 |
| Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics LB Travis, SD Fossa, HD Sesso, RD Frisina, DN Herrmann, CJ Beard, ... JNCI: Journal of the National Cancer Institute 106 (5), 2014 | 138 | 2014 |
| Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study SL Kerns, C Fung, PO Monahan, S Ardeshir-Rouhani-Fard, MIA Zaid, ... Journal of Clinical Oncology 36 (15), 1505, 2018 | 124 | 2018 |
